Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Trading Update

7 Jan 2013 07:00

RNS Number : 9109U
PureCircle Limited
07 January 2013
 



PURECIRCLE LIMITED

 

TRADING UPDATE

 

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia ingredients, today provides a trading update in respect of the six month period from 1 July 2012 to 31 December 2012, being the first half of its Financial Year 2013 (1H FY13). The Company's interim results for 1H FY13 will be announced on Wednesday 13 March 2013.

Sales

Sales in 1H FY13 are expected to be $27.3m, an increase of 80% against 1H FY12 ($15.2m). $26m of the sales are expected to be high purity stevia sweeteners and natural flavors, a 120% improvement against 1H FY12.There was growth in sales across all high purity ingredients primarily driven by new innovations in our Stevia PureCircle proprietary portfolio of all-natural, no-calorie sweeteners and natural flavor systems, under the PureCircle Flavors range.  By region, EMEA, Latin America, Asia Pacific and USA all recorded sales growth.

Sales volumes: In 1H FY13 total volumes of high purity stevia sweeteners and natural flavors are expected to increase by 135% against 1H FY12. Volume increases were led by sales of new proprietary ingredients introduced over the past twenty-four months.

 

EBITDA

The benefits of the increase in sales are expected to flow through the Profit and Loss account. Overall 1H FY13 EBITDA is expected to show an 80% improvement against 1H FY12 (EBITDA loss of $8.9m).

Cash, net debt and funding headroom

The Group ended 1H FY13 with gross cash of $45m, net debt of $67m and cash and facility headroom of $70m. The Group is sufficiently funded for its current expansion plans.

 

Commenting on the 1H FY13 trading, the Group CEO Magomet Malsagov said:  Our strategy of having a fully controlled, vertically integrated supply chain from leaf to finished products, of successfully developing and introducing to the market new proprietary natural sweeteners and flavors, of investing in applications and formulations as well as in global marketing and customer service capabilities, is beginning to yield results as can be seen by our performance in the first half of this fiscal year. New long term supply and joint development agreements with major global food and beverage (F&B) companies have been signed adding to our already strong portfolio of Global Key Accounts. Across the world, large F&B brands began to adopt our ingredients, most notably carbonated soft drinks (CSD's) including the important Cola category. We generate revenues from a wide range of natural sweeteners and flavors and we service globally hundreds of customers directly and through our business partners.

Our production capacity and customer service infrastructure are designed to deliver even greater volumes and revenues. As we continue to build on recent momentum, our guidance for sustained higher levels of market demand remains mid to long-term based.

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTNKADNCBKDQDK
Date   Source Headline
6th Jul 20157:00 amRNSPRECLOSE PERIOD UPDATE FY 2015
24th Apr 20157:00 amRNSAcquisition of remaining equity interest in PCJX
13th Apr 20157:23 amRNSDealings in Shares
10th Apr 20157:00 amRNSExercise of Options and Movement Treasury Shares
16th Mar 20157:00 amRNSInterim Results
9th Mar 20157:00 amRNSAnnouncement of Interim Results
28th Jan 20157:00 amRNSSustainability Report
27th Jan 20157:00 amRNSNotification of a Major Interest
14th Jan 20157:00 amRNSGrant of Options and Movement of Treasury Shares
5th Jan 20157:00 amRNSTrading Update
4th Dec 20147:00 amRNSResult of AGM
21st Nov 20147:00 amRNSHolding(s) in Company
12th Nov 20147:00 amRNSCompletion of Placement
11th Nov 20147:06 amRNSHolding(s) in Company
5th Nov 20147:00 amRNSNotice of AGM and Annual Report
4th Nov 20147:00 amRNSIncrease in Private Placement
22nd Oct 20147:00 amRNSDealings in Shares
21st Oct 20147:00 amRNSPrivate Placement to Support Accelerated Growth
14th Oct 20147:00 amRNSPublication of Annual Report
26th Sep 20147:00 amRNSDirector Share Transfer
19th Sep 20147:00 amRNSGrant of Options and Movement of Treasury Shares
10th Sep 20147:00 amRNSFinal Results
3rd Sep 20147:00 amRNSAnnouncement of Prelims & Investor Conference Call
4th Jul 20147:00 amRNSOptions Granted To and Exercised by Directors
2nd Jul 20147:04 amRNSPRECLOSE PERIOD UPDATE 2H FY 2014
17th Jun 20147:00 amRNSManagement Changes
10th Jun 20147:50 amRNSHolding(s) in Company
8th May 20147:00 amRNSDealings in Shares
2nd May 20147:00 amRNSExercise of Options
25th Apr 20147:00 amRNSDealings in Shares
8th Apr 20147:00 amRNSDirector's Shareholding
28th Mar 20147:00 amRNSExercise of Options
25th Mar 20147:50 amRNSHolding(s) in Company
19th Mar 20147:00 amRNSInterim Results
18th Mar 20147:00 amRNSBoard Change
10th Mar 20147:00 amRNSAnnouncement of Interim Results and Investor Call
10th Jan 20147:00 amRNSOptions Granted To and Exercised by Directors
6th Jan 20147:00 amRNSTrading Update
30th Dec 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside M
3rd Dec 20137:00 amRNSResult of AGM
28th Nov 20137:45 amRNSHolding(s) in Company
14th Nov 20137:00 amRNSDealings in Shares
6th Nov 20137:00 amRNSNotice of AGM and Annual Report
8th Oct 20137:00 amRNSLTIP Options Awarded - Options Issued to Directors
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20137:00 amRNSAppointment of Broker and New Financing Facility
2nd Sep 20137:00 amRNSAnnouncement of Prelims & Investor Conference Call
19th Jul 20138:13 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSChange of Brokers
9th Jul 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside D

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.